NCT07203833View on ClinicalTrials.gov

Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock

NANot yet recruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

May 31, 2027

Conditions
VasorinSeptic ShockShockBiomarkerInfection
Interventions
BIOLOGICAL

blood sample

To assess whether circulating Vasn can become a potential diagnostic biomarker of septic shock, we will measure the concentrations of circulating Vasn

Trial Locations (1)

80000

CHU Amiens-Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT07203833 - Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock | Biotech Hunter | Biotech Hunter